Ruixin Wang

685 total citations · 1 hit paper
39 papers, 444 citations indexed

About

Ruixin Wang is a scholar working on Molecular Biology, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ruixin Wang has authored 39 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ruixin Wang's work include Ubiquitin and proteasome pathways (4 papers), Epigenetics and DNA Methylation (4 papers) and Protein Degradation and Inhibitors (4 papers). Ruixin Wang is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Epigenetics and DNA Methylation (4 papers) and Protein Degradation and Inhibitors (4 papers). Ruixin Wang collaborates with scholars based in China, United States and Australia. Ruixin Wang's co-authors include Wenjun Mao, Jie Mei, He Zhao, Yongrui Xu, Xiaokun Wang, Guanyu Jiang, Kai Yang, Yifan Kong, Xiaoqi Liu and Guo JianFeng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Ruixin Wang

35 papers receiving 442 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The role of lipid metabolic reprogramming in tumor microenvironment

2023 125 citations Ruixin Wang, Wenjun Mao et al. profile →

Peers

Ruixin Wang

PRM

ONCOL

Judong Luo China

Fang‐Yi Huo China

Aihua Sui China

Yongwei Hu China

Jiangbo Ren China

Yongbiao Huang China

Danbi Seo South Korea

Bo Liang China

Maolong Wang China

Judong Luo China

Ruixin Wang

256 ×1.0

82 ×0.7

90 ×1.6

PRM

126 ×2.3

ONCOL

49 ×0.9

Citations per year, relative to Ruixin Wang Ruixin Wang (= 1×) peers Judong Luo

Countries citing papers authored by Ruixin Wang

Since Specialization

Citations

This map shows the geographic impact of Ruixin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruixin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruixin Wang more than expected).

Fields of papers citing papers by Ruixin Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruixin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruixin Wang. The network helps show where Ruixin Wang may publish in the future.

Co-authorship network of co-authors of Ruixin Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ruixin Wang. A scholar is included among the top collaborators of Ruixin Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruixin Wang. Ruixin Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Ruixin, Zhiyuan Wang, Yuanming Xiao, et al.. (2025). Application of deep learning on automated breast ultrasound: Current developments, challenges, and opportunities. SHILAP Revista de lepidopterología. 3(2). 100138–100138.

Cheng, Long, Hang Yu, Yujing Qin, et al.. (2025). The lncRNA ST18-AS1 suppresses pancreatic cancer progression by enhancing ST18 mRNA stability through anchoring FUS in the cytoplasm. Oncogene. 44(32). 2850–2863.

Wang, Yong, Liang Yin, Hailong Qiu, et al.. (2024). Evaluation of hemostatic, anti-inflammatory, wound healing, skin irritation and allergy, and antimicrobial properties of active fraction from the ethanol extract of Chromolaena odorata (L.) R.M. King & H. Rob. Journal of Ethnopharmacology. 331. 118330–118330. 2 indexed citations

Wang, Xiaokun, et al.. (2024). Microbiome and lung cancer: carcinogenic mechanisms, early cancer diagnosis, and promising microbial therapies. Critical Reviews in Oncology/Hematology. 196. 104322–104322. 12 indexed citations

Zhang, Yanquan, Ka-wing Fong, Fengyi Mao, et al.. (2024). Elevating PLK1 overcomes BETi resistance in prostate cancer via triggering BRD4 phosphorylation-dependent degradation in mitosis. Cell Reports. 43(7). 114431–114431. 9 indexed citations

Wei, Yue, Ruixin Wang, Jing Wang, et al.. (2023). Transitions in Metabolic Health Status and Obesity Over Time and Risk of Diabetes: The Dongfeng–Tongji Cohort Study. The Journal of Clinical Endocrinology & Metabolism. 108(8). 2024–2032. 4 indexed citations

Zhang, Jiazhen, Cheng Xu, Yue Wei, et al.. (2023). Epigenome-wide perspective of cadmium-associated DNA methylation and its mediation role in the associations of cadmium with lipid levels and dyslipidemia risk. Food and Chemical Toxicology. 184. 114409–114409. 1 indexed citations

Cai, Hua, Rongrong Zheng, Ruixin Wang, et al.. (2023). Chimeric Peptide Engineered Nanomedicine for Synergistic Suppression of Tumor Growth and Therapy-Induced Hyperlipidemia by mTOR and PCSK9 Inhibition. Pharmaceutics. 15(10). 2377–2377. 2 indexed citations

Li, Pengfei, Meixiang Chen, Ruixin Wang, et al.. (2023). Prognostic impact of in-hospital hemoglobin decline in non-overt bleeding ICU patients with acute myocardial infarction. BMC Cardiovascular Disorders. 23(1). 231–231. 1 indexed citations

10.

Li, Weiya, Zhaoyang Li, Yan Yan, et al.. (2023). Association of urinary arsenic metabolism with type 2 diabetes and glucose homeostasis: Cross-sectional and longitudinal associations.. Environmental Research. 239(Pt 2). 117410–117410.

11.

Wang, Fei, et al.. (2023). Research Progress on Anthocyanin-Mediated Regulation of ‘Black’ Phenotypes of Plant Organs. Current Issues in Molecular Biology. 45(9). 7242–7256. 4 indexed citations

12.

Wu, Zijuan, Danling Gu, Ruixin Wang, et al.. (2022). CircRIC8B regulates the lipid metabolism of chronic lymphocytic leukemia through miR199b-5p/LPL axis. Experimental Hematology and Oncology. 11(1). 51–51. 13 indexed citations

13.

Zhang, Zhuangzhuang, Lijun Cheng, Yifan Kong, et al.. (2021). Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer. Advanced Science. 8(13). e2101458–e2101458. 13 indexed citations

14.

He, Jia, Zhaoyang Li, Ruixin Wang, et al.. (2021). Association of blood pressure and long‐term change with chronic kidney disease risk among Chinese adults with different glucose metabolism according to the 2017 ACC/AHA guidelines. Journal of Clinical Hypertension. 23(12). 2080–2088. 2 indexed citations

15.

Zhang, Yanquan, Yifan Kong, Elia Farah, et al.. (2021). Epigenetics in prostate cancer treatment. PubMed. 5. 341–356. 11 indexed citations

16.

Jiang, Wencai, Meixiang Chen, Jianyu Huang, et al.. (2021). Proteinuria is independently associated with carotid atherosclerosis: a multicentric study. BMC Cardiovascular Disorders. 21(1). 554–554. 2 indexed citations

17.

Kong, Yifan, Yanquan Zhang, Fengyi Mao, et al.. (2020). Inhibition of EZH2 Enhances the Antitumor Efficacy of Metformin in Prostate Cancer. Molecular Cancer Therapeutics. 19(12). 2490–2501. 18 indexed citations

18.

Chen, Rongxin, Kai Zhang, Yifan Xiang, et al.. (2020). Differentiate cavernous hemangioma from schwannoma with artificial intelligence (AI). Annals of Translational Medicine. 8(11). 710–710. 12 indexed citations

19.

Wang, Ruixin, et al.. (2019). LINC00462 is involved in high glucose‐induced apoptosis of renal tubular epithelial cells via AKT pathway. Cell Biology International. 44(1). 286–294. 9 indexed citations

20.

Mao, Fengyi, Jie Li, Qian Luo, et al.. (2018). Plk1 Inhibition Enhances the Efficacy of BET Epigenetic Reader Blockade in Castration-Resistant Prostate Cancer. Molecular Cancer Therapeutics. 17(7). 1554–1565. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact